Namocell
Company

Last deal

Amount

Series A

Stage

01.05.2017

Date

1

all rounds

General

About Company
Namocell is an instrument company that revolutionizes single-cell research and therapeutics development in the biotech industry.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

By providing innovative single-cell sorting and dispensing platforms, Namocell empowers researchers and scientists in various fields such as genomics, cell line development, CRISPR, cell and gene therapy, stem cell research, monoclonal antibody development, rare cell isolation, and synthetic biology. Their user-inspired products offer the fastest and easiest way to identify and isolate single cells, allowing users to accomplish sorting and dispensing in a single step while maintaining the integrity of live cells. With a commitment to gentle cell handling, Namocell's solutions are tailored to meet the evolving needs of the biotech industry, enabling breakthrough discoveries and advancements in single-cell research and therapeutics.
Contacts